Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Provider profile

Major manufacturer savings-card programs — compounded GLP-1 pricing & profile

Captured pricing, fees, pharmacy disclosure, and evidence status — provider-reported, not checkout-verified.

Major manufacturer savings-card programs is a manufacturer / brand-access channel — a channel for FDA-approved products, profiled here for context but never ranked as a compounded provider. Compounded and approved products are different regulatory classes and are not compared on the same axis.

Provider-reported, not checkout-verified. This profile is built from captured public data and is not a scored, full editorial review. Major manufacturer savings-card programs is not assigned a score or a "verified cheapest" claim; figures are provided for transparency and comparison and should be confirmed with the provider.

Captured pricing

Major manufacturer savings-card programs does not publish a single flat compounded price in the captured data. Semaglutide: Eligible commercially insured patients may pay as little as $25/month for selected Novo Nordisk products, subject to limits and terms. Tirzepatide: Eligible commercially insured patients with Zepbound coverage may pay as little as $25 for a 1- or 3-month prescription, subject to limits and terms. Because no stable per-plan figure was captured, Major manufacturer savings-card programs is shown for transparency but is not placed in the ranked pricing tables. Confirm current pricing on the provider's own page before relying on any figure.

Fees, pharmacy, and disclosure

Major manufacturer savings-card programs — captured structure and disclosures (2026-07-20)
CategoryManufacturer / brand-access channel
Current statusAccess category — profile, never ranked as a provider
Membership / program feeMedication copay after savings
Pharmacy disclosureNot verified
Material relationshipNo known material relationship — publisher attested 2026-07-20; independent verification not performed
Evidence statusPROVIDER REPORTED · confidence high
Last checked2026-07-20
Official sourceprovider page

Capture note: Not available to government beneficiaries; “as low as” is not generally available cash pricing.

How to read this channel

As a manufacturer or brand-access channel, Major manufacturer savings-card programs supplies FDA-approved product, which carries premarket-reviewed manufacturing that compounded products do not. If you have insurance coverage or qualify for a manufacturer cash-pay program, an approved product can be cheaper and better-evidenced than any compounded option — price that first. See the brand-vs-compounded cost guide. This channel is never ranked against compounded providers.

Frequently asked questions

How much does Major manufacturer savings-card programs charge for compounded GLP-1?

Major manufacturer savings-card programs did not publish a single flat compounded price in the captured data — eligible commercially insured patients may pay as little as $25/month for selected novo nordisk products, subject to limits and terms. Confirm current pricing directly with the provider, and compute effective monthly cost at your maintenance dose before comparing.

Does Major manufacturer savings-card programs charge a membership fee?

As a brand-access channel, its fee structure differs from compounded telehealth. Captured: Medication copay after savings. A required membership belongs in the effective-cost math, so add it in before comparing Major manufacturer savings-card programs to any flat-priced provider.

Is Major manufacturer savings-card programs's pricing verified?

No. Major manufacturer savings-card programs's evidence status is provider reported (confidence high); figures are provider-reported or independently calculated, not checkout-verified, and its pharmacy disclosure is "not verified". Treat every figure as a starting point to confirm, not a guarantee.